- Advent Life Sciences participated in 6 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $205,895,062 (averaging $34,315,844 per round).
- Iterum Therapeutics: Venture capital (Series B) ($65M)
- Axonics Modulation Technologies: Venture capital (Series C) ($14.5M)
- Vestagen Technical Textiles Inc.: Venture capital ($10M)
- Neomed Management
- HealthQuest Capital
- Osage University Partners
Want to see the complete list?